Truist Financial’s Artivion AORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-9,110
Closed -$334K 2917
2026
Q1
$334K Sell
9,110
-5,218
-36% -$206K ﹤0.01% 2332
2025
Q4
$654K Sell
14,328
-1,393
-9% -$62K ﹤0.01% 1888
2025
Q3
$666K Sell
15,721
-1,982
-11% -$74.7K ﹤0.01% 1859
2025
Q2
$551K Buy
+17,703
New +$479K ﹤0.01% 1917
2013
Q3
Sell
-122,650
Closed -$768K 741
2013
Q2
$768K Buy
+122,650
New +$749K 0.03% 381

Other funds holding AORT

Truist Financial's AORT Position: Q2 2026 in Review

Truist Financial sold out of Artivion (AORT) in Q2 2026, closing a stake of 9,110 shares — an estimated $334K sold.

Truist Financial first reported a position in AORT in Q2 2013 and held it in 5 quarters. The position peaked at $768K in Q2 2013. 207 funds tracked by Wall St. Rank hold AORT as of Q2 2026.

  • Truist Financial reported no remaining Artivion position as of Q2 2026 after selling out during the quarter.
  • Truist Financial sold 9,110 Artivion shares in Q2 2026, an estimated $334K.
  • Truist Financial first reported a position in Artivion in Q2 2013 and held it in 5 quarters.
  • Truist Financial's Artivion position peaked at $768K in Q2 2013.
  • 207 funds tracked by Wall St. Rank held Artivion as of Q2 2026.

Based on Truist Financial's 13F filing for Q2 2026, filed 28 Jul 2026.